Premarket Mover: BioNTech SE - ADR (BNTX) Up 1.88%

BioNTech SE - ADR (BNTX) is higher by Thursday morning, with the stock rising 1.88% in pre-market trading to 284. BNTX's short-term technical score of 39 indicates that the stock has traded less bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 138 out of 146 industries, the stock ranks higher than 72% of stocks. BioNTech SE - ADR has fallen 9.22% over the past month, closing at $272.99 on September 30. During this period of time, the stock fell as low as $236.14 and as high as $304.35. BNTX has an average analyst recommendation of Buy. The company has an average price target of $274.00.

BNTX has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on BNTX!

See Full BNTX Report

BioNTech SE - ADR has a Long-Term Technical rank of 63. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 37% of the market scoring higher. In the Biotechnology industry which is number 140 by this metric, BNTX ranks better than 81% of stocks.

Important Dates for Investors in BNTX:

-BioNTech SE - ADR is set to release earnings on 11/7/2021. During their last earnings release the company posted EPS of $-1.04. -We do not have a set dividend date for BioNTech SE - ADR at this time. Click Here To Get The Full Report on BioNTech SE - ADR (BNTX)